$XCUR
Exicure Inc Stock $xcur

$xcur Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000169853020000034 Filed on May 14, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$9.183M	$25.00K
YoY Change	36632.0%	-30.56%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.570M	$2.210M
YoY Change	16.29%	7.8%
% of Gross Profit
Research & Development	$6.075M	$3.395M
YoY Change	78.94%	3.66%
% of Gross Profit
Depreciation & Amortization	$150.0K	$90.00K
YoY Change	66.67%	0.0%
% of Gross Profit
Operating Expenses	$8.649M	$5.603M
YoY Change	54.36%	5.32%
Operating Profit	$534.0K	-$5.578M
YoY Change	-109.57%	5.56%
Interest Expense	$128.0K	$183.0K
YoY Change	-30.05%	13.66%
% of Operating Profit	23.97%
Other Income/Expense, Net	$616.0K	$292.0K
YoY Change	110.96%	-229.78%
Pretax Income	$1.150M	-$5.290M
YoY Change	-121.74%	-3.99%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$1.150M	-$5.286M
YoY Change	-121.76%	-4.05%
Net Earnings / Revenue	12.52%	-21144.0%
Basic Earnings Per Share	$0.01	-$0.12
Diluted Earnings Per Share	$0.01	-$0.12
COMMON SHARES
Basic Shares Outstanding	87.08M shares	44.36M shares
Diluted Shares Outstanding	88.24M shares	44.36M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$98.80M	$22.20M
YoY Change	345.05%	5.21%
Cash & Equivalents	$24.58M	$22.20M
Short-Term Investments	$74.20M
Other Short-Term Assets	$2.500M	$1.400M
YoY Change	78.57%	-26.32%
Inventory
Prepaid Expenses	$1.219M	$559.0K
Receivables	$27.00K	$3.000K
Other Receivables	$400.0K	$0.00
Total Short-Term Assets	$101.7M	$23.62M
YoY Change	330.83%	2.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.298M	$977.0K
YoY Change	135.21%	-23.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.487M	$645.0K
YoY Change	130.54%	1915.63%
Total Long-Term Assets	$3.785M	$1.568M
YoY Change	141.39%	19.97%
TOTAL ASSETS
Total Short-Term Assets	$101.7M	$23.62M
Total Long-Term Assets	$3.785M	$1.568M
Total Assets	$105.5M	$25.18M
YoY Change	319.03%	3.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.392M	$848.0K
YoY Change	300.0%	-12.94%
Accrued Expenses	$1.268M	$1.786M
YoY Change	-29.0%	41.19%
Deferred Revenue		$975.0K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$4.807M
YoY Change	-100.0%	519.46%
Total Short-Term Liabilities	$20.37M	$8.221M
YoY Change	147.82%	172.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$0.00	$381.0K
YoY Change	-100.0%	37.55%
Total Long-Term Liabilities	$0.00	$381.0K
YoY Change	-100.0%	-91.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.37M	$8.221M
Total Long-Term Liabilities	$0.00	$381.0K
Total Liabilities	$20.42M	$9.029M
YoY Change	126.1%	12.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$80.15M	-$60.28M
YoY Change	32.96%	58.26%
Common Stock	$9.000K	$4.000K
YoY Change	125.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$85.11M	$16.16M
YoY Change
Total Liabilities & Shareholders Equity	$105.5M	$25.18M
YoY Change	319.03%	3.41%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	$1.150M	-$5.286M
YoY Change	-121.76%	-4.05%
Depreciation, Depletion And Amortization	$150.0K	$90.00K
YoY Change	66.67%	0.0%
Cash From Operating Activities	-$7.847M	-$4.012M
YoY Change	95.59%	-13.66%
INVESTING ACTIVITIES
Capital Expenditures	$577.0K	$8.000K
YoY Change	7112.5%
Acquisitions
YoY Change
Other Investing Activities	-$11.93M
YoY Change
Cash From Investing Activities	-$12.50M	-$8.000K
YoY Change	156187.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.973M	$0.00
YoY Change
Debt Paid & Issued, Net	$4.999M	$0.00
YoY Change
Cash From Financing Activities	-$2.333M	-$52.00K
YoY Change	4386.54%	-842.86%
NET CHANGE
Cash From Operating Activities	-$7.847M	-$4.012M
Cash From Investing Activities	-$12.50M	-$8.000K
Cash From Financing Activities	-$2.333M	-$52.00K
Net Change In Cash	-$22.68M	-$4.072M
YoY Change	457.05%	-12.24%
FREE CASH FLOW
Cash From Operating Activities	-$7.847M	-$4.012M
Capital Expenditures	$577.0K	$8.000K
Free Cash Flow	-$8.424M	-$4.020M
YoY Change	109.55%	-13.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001698530
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	87150447	shares
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1268000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3392000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16000	USD
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2020Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	EXICURE, INC.
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1814000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2435000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	35000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	254000	USD
CY2020Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	318000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1317000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1466000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	162062000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	165269000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	489000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	441000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	489000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	441000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	34000	USD
CY2019Q4	us-gaap	Assets Assets	115263000	USD
CY2020Q1	us-gaap	Assets Assets	105529000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	112776000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	101744000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	150000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	29000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	167000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	64851000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	74240000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	64824000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	74223000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	126000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48460000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24577000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26268000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22196000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48460000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25777000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4072000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22683000	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	86069263	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87150447	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86069263	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87150447	shares
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2020Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	148000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5286000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1160000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	21873000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2956000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	100000	USD
CY2020Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2019Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	87000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	920000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	386000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3944000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
CY2019Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-369000	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-346000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2208000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2574000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	354000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1807000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-52000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1108000	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	0	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2000	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	975000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-9116000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	559000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-30000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	341000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-59000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	62000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	911000	USD
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1165472	shares
CY2019Q1	us-gaap	Interest Expense InterestExpense	183000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	128000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	149000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	142000	USD
CY2019Q4	us-gaap	Interest Receivable InterestReceivable	236000	USD
CY2020Q1	us-gaap	Interest Receivable InterestReceivable	398000	USD
CY2019Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	105000	USD
CY2020Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	39000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	360000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	174000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	179000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Renewal Term1 LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1	P5Y
CY2020Q1	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P10Y
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	294000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	59000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	235000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19000	USD
CY2020Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1200000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	34516000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	20415000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	115263000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	105529000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31087000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	20373000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4965000	USD
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-52000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2333000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12503000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4012000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7847000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-5286000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1150000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	292000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	616000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	5603000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	8649000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5578000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	534000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	84000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	84000	USD
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	275000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	292000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	275000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	59000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	277000	USD
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.161
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y11M
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	114000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	356000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	285000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1487000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	454000	USD
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	137000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	32000	USD
CY2020Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	388000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	10000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	59000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	369000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	345000	USD
CY2019Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	36000	USD
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	84000	USD
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	705000	USD
CY2020Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	920000	USD
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	52000	USD
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	100000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	21926000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	577000	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1955000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2906000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	481000	USD
CY2020Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1219000	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	533000	USD
CY2020Q1	us-gaap	Prepaid Insurance PrepaidInsurance	369000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2973000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	10000000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3416000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3764000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2099000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2298000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2020Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4999000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3395000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6075000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	1200000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81297000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80147000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9183000	USD
CY2019Q1	us-gaap	Revenues Revenues	25000	USD
CY2020Q1	us-gaap	Revenues Revenues	9183000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	489000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	441000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	2.80
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0256
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0168
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4164925	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.06
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1211704	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.01
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.89
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5697714	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6909418	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.34
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.15
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1461000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4625000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1492000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6693125	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.15
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.27
CY2019Q1	us-gaap	Share Price SharePrice	2.80
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1172000	USD
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M12D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M6D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	62326000	USD
CY2020Q1	us-gaap	Short Term Investments ShortTermInvestments	74223000	USD
CY2019Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	6000	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	38000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2766000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	20952000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	16155000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	80747000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	85114000	USD
CY2019Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	19000	USD
CY2020Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	11000	USD
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	84000	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	57000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44358000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88244632	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44358000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87079160	shares
CY2019Q4	xcur	Accrued Clinical Contract Research And Manufacturing Costs Current AccruedClinicalContractResearchAndManufacturingCostsCurrent	515000	USD
CY2020Q1	xcur	Accrued Clinical Contract Research And Manufacturing Costs Current AccruedClinicalContractResearchAndManufacturingCostsCurrent	152000	USD
CY2020Q1	xcur	Common Stock Voting Rightsfor Each Share CommonStockVotingRightsforEachShare	1	vote_per_share
CY2019Q4	xcur	Common Stock Warrant Liability CommonStockWarrantLiability	414000	USD
CY2020Q1	xcur	Common Stock Warrant Liability CommonStockWarrantLiability	42000	USD
CY2020Q1	xcur	Debt Securities Available For Sale Current Percent DebtSecuritiesAvailableForSaleCurrentPercent	0.64
CY2020Q1	xcur	Debt Securities Available For Sale Noncurrent Percent DebtSecuritiesAvailableForSaleNoncurrentPercent	0.36
CY2020Q1	xcur	Debt Securities Availablefor Sale Percent DebtSecuritiesAvailableforSalePercent	1.00
CY2020Q1	xcur	Fair Value Assumptions Impact Of10 Percent Change In Expected Volatility Rate FairValueAssumptionsImpactOf10PercentChangeInExpectedVolatilityRate	18000	USD
CY2020Q1	xcur	Fair Value Assumptions Impact Of10 Percent Change In Fair Value Of Common Stock FairValueAssumptionsImpactOf10PercentChangeInFairValueOfCommonStock	19000	USD
CY2020Q1	xcur	Lessee Operating Lease Lease Not Yet Commenced Annual Base Rate Initial Twelve Months LesseeOperatingLeaseLeaseNotYetCommencedAnnualBaseRateInitialTwelveMonths	37.00
CY2020Q1	xcur	Lessee Operating Lease Lease Not Yet Commenced Annual Rent Payment Initial Twelve Months LesseeOperatingLeaseLeaseNotYetCommencedAnnualRentPaymentInitialTwelveMonths	1113000	USD
CY2020Q1	xcur	Lessee Operating Lease Lease Not Yet Commenced Base Rent Annual Percentage Increase LesseeOperatingLeaseLeaseNotYetCommencedBaseRentAnnualPercentageIncrease	0.03
CY2020Q1	xcur	Lessee Operating Lease Lease Not Yet Commenced Estimated Rental Payment Over Original Term LesseeOperatingLeaseLeaseNotYetCommencedEstimatedRentalPaymentOverOriginalTerm	12761000	USD
CY2020Q1	xcur	Lessee Operating Lease Lease Not Yet Commenced Landlord Contribution Towards Tenant Improvement LesseeOperatingLeaseLeaseNotYetCommencedLandlordContributionTowardsTenantImprovement	3159000	USD
CY2020Q1	xcur	Lessee Operating Lease Lease Not Yet Commenced Lease Area LesseeOperatingLeaseLeaseNotYetCommencedLeaseArea	30000	sqft
CY2020Q1	xcur	Lessee Operating Lease Lease Not Yet Commenced Numberof Extensions LesseeOperatingLeaseLeaseNotYetCommencedNumberofExtensions	2	squarefeet
CY2020Q1	xcur	Lessee Operating Lease Lease Not Yet Commenced Rental Payment Adjusted For Abatement LesseeOperatingLeaseLeaseNotYetCommencedRentalPaymentAdjustedForAbatement	87000	USD
CY2019Q1	xcur	Payments Of Common Stock Financing Costs PaymentsOfCommonStockFinancingCosts	0	USD
CY2020Q1	xcur	Payments Of Common Stock Financing Costs PaymentsOfCommonStockFinancingCosts	207000	USD
CY2020Q1	xcur	Paymentsfor License Agreements PaymentsforLicenseAgreements	8198000	USD
CY2020Q1	xcur	Percentageof Researchand Development Staff Onsiteat Any One Time PercentageofResearchandDevelopmentStaffOnsiteatAnyOneTime	0.50
CY2020Q1	xcur	Retained Earnings Accumulated Deficit Inceptionto Date RetainedEarningsAccumulatedDeficitInceptiontoDate	-98984000	USD
CY2019Q1	xcur	Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate	0.05
CY2020Q1	xcur	Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate	0.05
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on certain assumptions which it believes are reasonable in the circumstances and while actual results could differ from those estimates, management does not believe that any change in those assumptions in the near term would have a significant effect on the Company’s financial position, results of operations or cash flows. Actual results in future periods could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001698530-20-000034-index-headers.html	Edgar Link	pending
0001698530-20-000034-index.html	Edgar Link	pending
0001698530-20-000034.txt	Edgar Link	pending
0001698530-20-000034-xbrl.zip	Edgar Link	pending
a2019developmentpipeline10k5.jpg	Edgar Link	pending
a2430nhalstedleasefin_image3.jpg	Edgar Link	pending
a2430nhalstedleasefin_image4.jpg	Edgar Link	pending
a2430nhalstedleasefin_image5.jpg	Edgar Link	pending
a2430nhalstedleasefin_image6.jpg	Edgar Link	pending
capture.jpg	Edgar Link	pending
exicure10q33120.htm	Edgar Link	pending
exicureexhibit1012-3312020.htm	Edgar Link	pending
exicureexhibit311-33120.htm	Edgar Link	pending
exicureexhibit312-33120.htm	Edgar Link	pending
exicureexhibit321-33120.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
map.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xcur-20200331.xml	Edgar Link	completed
xcur-20200331.xsd	Edgar Link	pending
xcur-20200331_cal.xml	Edgar Link	unprocessable
xcur-20200331_def.xml	Edgar Link	unprocessable
xcur-20200331_lab.xml	Edgar Link	unprocessable
xcur-20200331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XCUR
Exicure Inc Stock $xcur

2020 Q1 Form 10-Q Financial Statement

#000169853020000034 Filed on May 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XCUR Exicure Inc Stock $xcur

2020 Q1 Form 10-Q Financial Statement

#000169853020000034 Filed on May 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XCUR
Exicure Inc Stock $xcur